Famed Hammersmith Hospital in London, one of the first healthcare facilities in the world to embrace PACS, claims to be one of the world's first "virtual" hospitals.The reengineering or streamlining of all workflow areas throughout the enterprise is
Famed Hammersmith Hospital in London, one of the first healthcare facilities in the world to embrace PACS, claims to be one of the world's first "virtual" hospitals.
The reengineering or streamlining of all workflow areas throughout the enterprise is complete, all computerized systems have been integrated, and a paperless as well as filmless environment has been achieved, according to Dr. Nicola H. Strickland, a consultant radiologist and senior lecturer in Hammersmith's department of imaging.
All that, plus the introduction of Web browser technology and the integration of teleradiology, makes Hammersmith a "virtual" hospital, she said.
The workflow reengineering was enabled by PACS, Strickland said. Though proven as a clinical tool, most PACS must still justify themselves financially by providing added value to the enterprise. Workflow reengineering is one such added value. Certain specialized software packages, such as remote teleconferencing and exploitation of Web browser technology, are integral to the virtual hospital.
"These have important financial benefits, since they support academic activities such as publishing and teaching, as well as clinical purposes," she said.
Four new DICOM concepts helped facilitate Hammersmith's virtual migration:
"Previously, additional steps had to be included as separate imaging examinations, an inconvenient process for the user," Strickland said.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.